Kerry Flom
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
-
- Epigenetics and DNA Methylation 2
- Glycosylation and Glycoproteins Research 2
- Oncology 4
- HER2/EGFR in Cancer Research 3
- Lung Cancer Research Studies 2
- Co-authors
- Leslie Bernstein (4 shared papers)Dennis J. Slamon (3 shared papers)Michael F. Press (3 shared papers)Jinha Park (1 shared paper)Jianyuan Zhou (1 shared paper)Gene Hung (1 shared paper)Jeffrey S. Ross (1 shared paper)Jian Zhou (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)The Journal of Urology (2 papers)Clinical Chemistry (1 paper)Diagnostic Cytopathology (1 paper)American Journal of Medical Genetics (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Kerry Flom
10 papers receiving 1.5k citations
Kerry Flom's Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 976
- Cancer Research 368
- Radiology, Nuclear Medicine and Imaging 558
- Urology 93
- Immunology and Allergy 63
Countries citing papers authored by Kerry Flom
This map shows the geographic impact of Kerry Flom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Flom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Flom more than expected).
Fields of papers citing papers by Kerry Flom
This network shows the impact of papers produced by Kerry Flom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Flom. The network helps show where Kerry Flom may publish in the future.
Co-authors
The 25 scholars most cited alongside Kerry Flom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. Hit paper breakdown → | 1997 | 643 |
| 2 | 2002 | 312 | |
| 3 | 2002 | 214 | |
| 4 | 2002 | 194 | |
| 5 | 2010 | 146 | |
| 6 | 1994 | 46 | |
| 7 | 2005 | 7 | |
| 8 | 1995 | 6 | |
| 9 | 1991 | 3 | |
| 10 | 2002 | 2 |
About Kerry Flom
Kerry Flom is a scholar working on Molecular Biology, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 10 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), HER2/EGFR in Cancer Research (3 papers), Urinary and Genital Oncology Studies (2 papers), Epigenetics and DNA Methylation (2 papers), Glycosylation and Glycoproteins Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Lung Cancer Research Studies (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). The work is most often cited by research in Oncology (976 citations), Cancer Research (368 citations), Radiology, Nuclear Medicine and Imaging (558 citations), Urology (93 citations) and Immunology and Allergy (63 citations). Kerry Flom has collaborated with scholars based in United States and Germany. Frequent co-authors include Leslie Bernstein, Dennis J. Slamon, Michael F. Press, Jinha Park, Jianyuan Zhou, Gene Hung, Jeffrey S. Ross, Jian Zhou, L F Meisner and Robert A. Robinson. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Clinical Chemistry, Diagnostic Cytopathology and American Journal of Medical Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.